Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mutations in epidermal growth factor receptor and K-ras in Chinese patients with colorectal cancer.

BMC medical genetics - 26 Feb 2010

Yunxia Zuo, Jun Cao, Guanshan Zhu, Yachao Lu, Xueke Zhou, Jin Li

Abstract excerpt

BACKGROUND: Mutations of EGFR and K-ras are biomarkers for predicting the efficacy of targeting agents in non-small-cell lung cancer (NSCLC) and colorectal cancer (CRC). Data on the gene mutation status of EGFR and K-ras in Chinese patients with CRC are limited. METHODS: EGFR mutations in exon 18...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Asian People
Share to Base Sequence
Share to China

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Colorectal Neoplasms

Share to Genes, erbB-1

Share to Genes, ras

Share to Multivariate Analysis

Share to Survival Analysis

Source

Open in PubMed Open full text

Identifiers

PMID: 20184776
DOI: 10.1186/1471-2350-11-34
PMCID: PMC2848222

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20184776-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mutations in epidermal growth factor receptor and K-ras in Chinese patients with colorectal cancer.PMID 20184776Read ↗

[Mutational analysis of EGFR and K-RAS in Chinese patients with non-small cell lung cancer].Semantic proximity Read ↗

[Relationship between EGFR and K-ras mutations and clinicopathological characteristics and response to erlotinib treatment in 301 Chinese patients with non-small cell lung cancer].Semantic proximity Read ↗

Detection of K-ras Mutations in Predicting Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase (EGFR-TK) Inhibitor in Patients with Metastatic Colorectal Cancer.Semantic proximity Read ↗

Mutation status and prognostic values of KRAS, NRAS, BRAF and PIK3CA in 353 Chinese colorectal cancer patients.Semantic proximity Read ↗

EGFR/KRAS mutations and gefitinib therapy in Chinese NSCLC patients.Semantic proximity Read ↗

Clinical significance of K-ras and BRAF mutations in Chinese colorectal cancer patients.Semantic proximity Read ↗

[Mutations of KRAS and BRAF in Chinese patients with colorectal carcinoma: analyses of 966 cases].Semantic proximity Read ↗

The human epidermal growth factor receptor (EGFR) gene in European patients with advanced colorectal cancer harbors infrequent mutations in its tyrosine kinase domain.Semantic proximity Read ↗

Can K-ras gene mutation be utilized as prognostic biomarker for colorectal cancer patients receiving chemotherapy? A meta-analysis and systematic review.Semantic proximity Read ↗

Molecular spectrum of KRAS, NRAS, BRAF and PIK3CA mutations in Chinese colorectal cancer patients: analysis of 1,110 cases.Semantic proximity Read ↗

Mutations in K-ras and epidermal growth factor receptor expression in Korean patients with stages III and IV colorectal cancer.Semantic proximity Read ↗

Mutations in BRAF correlate with poor survival of colorectal cancers in Chinese population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.